Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company based in China, dedicated to the research, development, and commercialization of therapies for eye diseases. Spun off from Lee's Pharmaceutical, the company has built a comprehensive pipeline covering both front-of-the-eye and back-of-the-eye indications, including dry eye disease, glaucoma, and wet age-related macular degeneration. Its lead candidate, a Cyclosporine A ophthalmic gel, is positioned as a potential best-in-class treatment for dry eye. Zhaoke operates a state-of-the-art manufacturing facility in Nansha, Guangzhou, and maintains strategic partnerships with global biotech firms to expand its portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaoke Pharmaceuticals.